Anterior chamber and vitreous concordance in endophthalmitis: Implications for prophylaxis

Archives of Ophthalmology

Volumn 128, Issue 9, 2010, Pages 1136-1139

  Almeida, David R P ^a   Miller, Darlene ^b   Alfonso, Eduardo C ^b  

^a QUEEN S UNIVERSITY   (Canada)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTAZIDIME; CIPROFLOXACIN; GATIFLOXACIN; GENTAMICIN; LEVOFLOXACIN; MOXIFLOXACIN; VANCOMYCIN; ANTIINFECTIVE AGENT;

ANTERIOR EYE CHAMBER; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ARTICLE; CASE CONTROL STUDY; ENDOPHTHALMITIS; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; VITREOUS BODY; BACTERIAL EYE INFECTION; DRUG EFFECT; FUNGUS; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; ISOLATION AND PURIFICATION; LABORATORY DIAGNOSIS; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; PREDICTION AND FORECASTING; RETROSPECTIVE STUDY; STATISTICAL MODEL;

ANTERIOR CHAMBER; ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; CASE-CONTROL STUDIES; DRUG RESISTANCE, BACTERIAL; ENDOPHTHALMITIS; EYE INFECTIONS, BACTERIAL; FALSE POSITIVE REACTIONS; FUNGI; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HUMANS; LIKELIHOOD FUNCTIONS; MICROBIAL SENSITIVITY TESTS; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; VITREOUS BODY;

EID: 77957001169     PISSN: 00039950     EISSN: 15383601     Source Type: Journal    
DOI: 10.1001/archophthalmol.2010.202     Document Type: Article

References (31)

1. Endophthalmitis Vitrectomy Study Group. Results of the Endophthalmitis Vitrectomy Study: a randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis. Arch Ophthalmol. 1995;113(12):1479-1496.
2. Buzard K, Liapis S. Prevention of endophthalmitis. J Cataract Refract Surg. 2004; 30(9):1953-1959.
3. O'Brien TP. Evidence-based review of moxifloxacin. Int Ophthalmol Clin. 2006;46 (4):61-72.
4. Lemley CA, Han DP. Endophthalmitis: a review of current evaluation and management [published correction appears in Retina. 2007;27(7)]. Retina. 2007; 27(6):662-680.
5. Javitt JC, Street DA, Tielsch JM, et al; Cataract Patient Outcomes Research Team. National outcomes of cataract extraction: retinal detachment and endophthalmitis after outpatient cataract surgery. Ophthalmology. 1994;101(1):100-105, discussion 106.
6. Norregaard JC, Thoning H, Bernth-Petersen P, Andersen TF, Javitt JC, Anderson GF. Risk of endophthalmitis after cataract extraction: results from the International Cataract Surgery Outcomes study. Br J Ophthalmol. 1997;81(2):102-106.
7. Somani S, Grinbaum A, Slomovic AR. Postoperative endophthalmitis: incidence, predisposing surgery, clinical course and outcome. Can J Ophthalmol. 1997;32(5):303-310.
8. Aaberg TM Jr, Flynn HW Jr, Schiffman J, Newton J. Nosocomial acute-onset postoperative endophthalmitis survey: a 10-year review of incidence and outcomes. Ophthalmology. 1998;105(6):1004-1010.
9. Morlet N, Gatus B, Coroneo M. Patterns of peri-operative prophylaxis for cataract surgery: a survey of Australian ophthalmologists. Aust N Z J Ophthalmol. 1998;26(1):5-12.
10. Endophthalmitis Study Group, European Society of Cataract & Refractive Surgeons. Prophylaxis of postoperative endophthalmitis following cataract surgery: results of the ESCRS multicenter study and identification of risk factors. J Cataract Refract Surg. 2007;33(6):978-988.
11. Busbee BG. Endophthalmitis: a reappraisal of incidence and treatment. Curr Opin Ophthalmol. 2006;17(3):286-291.
12. Kampougeris G, Antoniadou A, Kavouklis E, Chryssouli Z, Giamarellou H. Penetration of moxifloxacin into the human aqueous humour after oral administration. Br J Ophthalmol. 2005;89(5):628-631.
13. Katz HR, Masket S, Lane SS, et al. Absorption of topical moxifloxacin ophthalmic solution into human aqueous humor. Cornea. 2005;24(8):955-958.
14. Kim DH, Stark WJ, O'Brien TP, Dick JD. Aqueous penetration and biological activity of moxifloxacin 0.5% ophthalmic solution and gatifloxacin 0.3% solution in cataract surgery patients. Ophthalmology. 2005;112(11):1992-1996.
15. Scoper SV. Review of third- and fourth-generation fluoroquinolones in ophthalmology: in-vitro and in-vivo efficacy. Adv Ther. 2008;25(10):979-994.
16. Barry P, Seal DV, Gettinby G, Lees F, Peterson M, Revie CW; ESCRS Endophthalmitis Study Group. ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery: preliminary report of principal results from a European multicenter study. J Cataract Refract Surg. 2006;32(3):407-410.
17. Brown SM, Anand VK, Tabaee A, Schwartz TH. Role of perioperative antibiotics in endoscopic skull base surgery. Laryngoscope. 2007;117(9):1528- 1532.
18. Flynn HW Jr, Scott IU, Brod RD, Han DP. Current management of endophthalmitis. Int Ophthalmol Clin. 2004;44(4):115-137.
19. Ou JI, Ta CN. Endophthalmitis prophylaxis. Ophthalmol Clin North Am. 2006;19 (4):449-456.
20. Ciulla TA, Starr MB, Masket S. Bacterial endophthalmitis prophylaxis for cataract surgery: an evidence-based update. Ophthalmology. 2002;109(1):13-24.
21. Pewsner D, Battaglia M, Minder C, Marx A, Bucher HC, Egger M. Ruling a diagnosis in or out with "SpPIn" and "SnNOut": a note of caution. BMJ. 2004;329 (7459):209-213.
22. Seal D, Reischl U, Behr A, et al; ESCRS Endophthalmitis Study Group. Laboratory diagnosis of endophthalmitis: comparison of microbiology and molecular methods in the European Society of Cataract & Refractive Surgeons multicenter study and susceptibility testing. J Cataract Refract Surg. 2008;34(9):1439-1450.
23. Barza M, Pavan PR, Doft BH, et al. Evaluation ofmicrobiological diagnostic techniques in postoperative endophthalmitis in the Endophthalmitis Vitrectomy Study. Arch Ophthalmol. 1997;115(9):1142-1150.
24. Recchia FM, Busbee BG, Pearlman RB, Carvalho-Recchia CA, Ho AC. Changing trends in the microbiologic aspects of postcataract endophthalmitis. Arch Ophthalmol. 2005;123(3):341-346.
25. Benz MS, Scott IU, Flynn HW Jr, Unonius N, Miller D. Endophthalmitis isolates and antibiotic sensitivities: a 6-year review of culture-proven cases. Am J Ophthalmol. 2004;137(1):38-42.
26. Harper T, Miller D, Flynn HW Jr. In vitro efficacy and pharmacodynamic indices for antibiotics against coagulase-negative staphylococcus endophthalmitis isolates. Ophthalmology. 2007;114(5):871-875.
27. Miller D, Flynn PM, Scott IU, Alfonso EC, Flynn HW Jr. In vitro fluoroquinolone resistance in staphylococcal endophthalmitis isolates. Arch Ophthalmol. 2006; 124(4):479-483.
28. Ta CN. Topical antibiotic prophylaxis in intraocular injections. Arch Ophthalmol. 2007;125(7):972-974.
29. Deramo VA, Lai JC, Fastenberg DM, Udell IJ. Acute endophthalmitis in eyes treated prophylactically with gatifloxacin and moxifloxacin. Am J Ophthalmol. 2006; 142(5):721-725.
30. Jensen MK, Fiscella RG, Moshirfar M, Mooney B. Third- and fourth-generation fluoroquinolones: retrospective comparison of endophthalmitis after cataract surgery performed over 10 years. J Cataract Refract Surg. 2008;34(9):1460-1467.
31. McCulley JP. Fluoroquinolones and postoperative endophthalmitis. J Cataract Refract Surg. 2009;35(2):206.